Title:
TARGETED RNA CIRCULARIZATION
Document Type and Number:
WIPO Patent Application WO/2024/030456
Kind Code:
A3
Abstract:
The disclosure provides nucleic acid constructs for cell- and tissue-specific targeting of therapeutic and diagnostic agents.
Inventors:
O'HAGAN DAVID (US)
MELVILLE DAVID (US)
MELVILLE DAVID (US)
Application Number:
PCT/US2023/029252
Publication Date:
April 25, 2024
Filing Date:
August 01, 2023
Export Citation:
Assignee:
ESPEROVAX INC (US)
International Classes:
C12N15/113; A61K47/69; A61K48/00; C12N15/11; C12N15/63
Attorney, Agent or Firm:
LORENZ, Todd et al. (US)
Download PDF: